Andrew Cazares

6505--Imatinib Tablets

The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Oct 16, 2026

36E79726R0036

4d left

Federal1

6505--Droxidopa Capsules (VA-27-00007975)

The Department of Veterans Affairs is conducting market research for a national mandatory requirements contract to procure Droxidopa Capsules for the VA, Department of Defense, Indian Health Service, Bureau of Prisons, and Federal Health Care Center. The procurement covers three strengths in 90-count bottles: 100mg with an estimated annual usage of 6,160 bottles, 200mg with 3,587 bottles, and 300mg with 3,738 bottles. The government intends to award the contract in the aggregate for all strengths and sizes, preferring a base year with up to four option years. The primary goal is to secure pricing lower than FSS or Open Market rates based on committed volumes, with a requirement that the successful contractor can begin supply within 60 days of the award. To qualify, offerors must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and the contractor's label must be the only label on the product. Non-manufacturers must provide a letter of commitment from the manufacturer ensuring a sufficient source of supply. Additionally, contractors must have executed chargeback agreements with Pharmaceutical Prime Vendors (PPV) for distribution. Strict packaging specifications are required for unit of use 90-count bottles, including a child-proof closure, a minimum 120cc volume, a cylindrical body with at least a 5.75-inch circumference, and a label size of 5.25 by 2 inches with a 0.5-inch space for barcodes and expiration data. The procurement falls under NAICS code 325412 and requires confirmation of U.S.-made or Trade Agreements Act status.

Department Of Veterans AffairsDepartment of Veterans Affairs OPAL / National Acquisition Center, Hines, IL, 60141,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Aug 28, 2026

36E79726Q0004

Closed

Awarded3

6505--Benazepril HCL Tablets

This contract, solicitation number 36E79726R0026, is an award notice issued by the Department of Veterans Affairs through its National Acquisition Center in Hines, Illinois, for the procurement of Benazepril HCl tablets in various strengths and packaging sizes. The contract is structured as a requirements-type agreement with a one-year base period and four one-year option periods, allowing for a potential total performance duration of five years. The government will order specific quantities of 5 mg, 10 mg, 20 mg, and 40 mg tablets, available in both 100-count and 500-count bottles, with estimated annual volumes defined for each line item. Delivery must be made to designated Prime Vendor distribution centers operated by McKesson Corporation and other authorized Prime Vendor contractors under the VA and DoD pharmaceutical supply systems. The contract is awarded on a Lowest Price Technically Acceptable basis, meaning selection will be based on the lowest evaluated price among proposals that meet all mandatory technical, regulatory, and compliance standards. No cost estimates are provided in the solicitation, and pricing is to be submitted by offerors for all base and option year quantities. The contractor must comply with stringent pharmaceutical and packaging standards, including FDA current Good Manufacturing Practices and USP-NF quality requirements. All products must feature child-resistant closures, be packaged in non-glass containers, and be fully compatible with automated dispensing systems such as Baxter ATC Canisters and Optifill. Labeling must include an exact drug name and strength, a unique 11-digit NDC number as the sole primary label, and barcodes conforming to GS1-128 or HIBCC standards with specific placement and readability requirements. A two-dimensional data matrix barcode is required for the lowest saleable unit per DSCSA regulations. The contractor must disclose all packaging and repackaging facility locations, including FEI numbers, and ensure all sites are in substantial compliance with cGMP. Contractual obligations extend to small business subcontracting requirements, mandating a VA-specific subcontracting plan with targets for SDVOSBs and VOSBs, prompt payment to small business subcontractors within 30 days, and adherence to VAAR 852.219-70 and related clauses. Additional compliance areas include whistleblower protections, contractor responsibility updates, system for award management maintenance, and security prohibitions. Offers must be submitted electronically via email before the deadline of May 21, 20

Department Of Veterans AffairsIL, USA$3.7M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79726R0026

Awarded

Awarded5

6505--PuraCap Contract Award Venlafaxine 24HR SA Capsules

The contract awards the supply of Venlafaxine HCL 24HR SA Capsules in multiple strengths and package sizes to the Department of Veterans Affairs through the National Acquisition Center in Hines, Illinois, under solicitation number 36E79726R0010. The scope encompasses end-to-end manufacturing, packaging, labeling, and distribution of pharmaceutical products compliant with FDA cGMP, USP-NF standards, and the Drug Supply Chain Security Act (DSCSA). Key deliverables include unit-of-use packaging with child-resistant safety caps, minimum 120cc cylindrical bottles, 5.25” x 2” labeling space, and mandatory GS1-128 or HIBCC-compliant barcodes meeting ANSI/ISO/IEC Grade C quality standards at the lowest saleable unit, with NDC, lot number, and expiration date encoded in both machine- and human-readable formats. All operations must occur at FDA-inspected facilities, with full disclosure of manufacturing, repackaging, and labeling locations and FEI numbers required. The contract includes a one-year base period with four one-year option periods, exercisable unilaterally by the government, and delivery is governed by FOB origin or destination terms as specified in individual orders, with acceptance occurring at government ordering facilities. Pricing details are not provided in the solicitation, indicating that offerors must submit their own unit and extended prices for each CLIN, with all bids subject to a mandatory 0.5% cost recovery fee. Compliance with VA-specific clauses is required, including FAR 52.212-4 (commercial items), FAR 52.216-21 (requirements), FAR 52.217-9 (options), and VA deviation clauses for commercial services and subcontracting. A Small Business Subcontracting Plan, as outlined in VAAR 852.219-70, is mandatory, and a subcontracting plan template is referenced. Contractors must provide a unique NDC for each product, avoid EULA or TOS indemnification that conflicts with the Anti-Deficiency Act, and certify compliance with Buy American provisions. Payment is processed through Pharmacy Provider Vendor systems, not directly by the government, and invoices must adhere to Prompt Payment Act requirements. Proposals must be submitted electronically via email to designated VA contacts in Word or PDF format, excluding compressed files or faxes, and must include a completed SF-1449 with

Department Of Veterans AffairsIL, USA$32.4M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79726R0010

Awarded

Awarded4

6505--Bumetanide Tablets

The contract involves the procurement of Bumetanide Tablets for the Department of Veterans Affairs, with a solicitation issued on October 24, 2025, and an amended deadline extended to November 20, 2025. It is structured as a multi-year requirements contract, with a base period and four one-year options, covering various dosages and bottle sizes. The government will award the contract in the aggregate to the lowest-priced, technically acceptable offeror that meets all technical and compliance requirements, including FDA cGMP standards and USP-NF specifications. Offerors must submit prices for all line items, including a 0.5% Cost Recovery Fee, with prices evaluated on an estimated quantity basis, though no specific total contract value is provided. The delivery is FOB destination to multiple VA and DoD distribution centers nationwide, with a requirement that products be shipped within 15 days of order receipt and no more than 15 days after contract expiration. The solicitation emphasizes strict packaging, labeling, and bar-coding standards aligned with GS1-128, HIBCC, and ANSI/ISO/IEC Grade C standards to ensure product traceability and integrity. Inspection and acceptance occur at the government’s destination facilities, with the government responsible for verifying conformance to quality standards and FDA regulations. The contract incorporates numerous FAR clauses covering representations, certifications, subcontracting plans, privacy, security, and prohibitions on certain technologies and entities. Offerors must submit proposals via email in Word or PDF format by the deadline, including a signed SF-1449, completed certifications, and all required documentation. The process is designed to ensure compliance, transparency, and adherence to federal procurement standards, with award based on price and technical acceptability.

Department Of Veterans AffairsIL, USA$5.6M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0068

Awarded

Awarded1

6505--Ambrisentan Tablets (VA-26-00005803)

The Department of Veterans Affairs awarded contract 36E79726D0005 to Golden State Medical Supply, Inc. for the procurement of Ambrisentan Tablets. The total award amount is 6,933,952.53 dollars, with the award finalized on November 7, 2025, following solicitation 36E79725R0056. This procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and Product Service Code 6505 for Health Care Goods. The contract is administered by the OPAL National Acquisition Center in Hines, Illinois, with Andrew J. Cazares serving as the Contracting Officer. The scope of work involves the supply and delivery of generic pharmaceutical tablets to meet federal requirements, implying compliance with FDA and USP standards. While the awardee is located in Camarillo, California, specific delivery schedules, FOB terms, and detailed pricing structures were not disclosed in the available documentation. The contract was issued as an unrestricted procurement with no socioeconomic set-asides.

Department Of Veterans AffairsIL, USA$6.9M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0056

Awarded

Awarded1

6505--Acyclovir Capsules

The Department of Veterans Affairs, specifically through the NAC Pharmaceuticals office, awarded a contract for Acyclovir Capsules under solicitation number 36E79725R0033. The award, titled "6505--Acyclovir Capsules," was posted on July 22, 2025, with an official award notice issued the same day. The contract has a total value of $3,172,038.20 and was awarded to Golden State Medical Supply, Inc., headquartered in Camarillo, California. The NAICS code associated with this procurement is 325412, which pertains to Pharmaceutical Preparation Manufacturing. The point of contact for this contract is Andrew J. Cazares, Contracting Officer, who can be reached at [phone hidden] or via email at [email hidden]. While the place of performance is not specified, the awarding office is located in Hines, Illinois. The awarded contract number is 36E79725D0049, and the public can view more details about the opportunity through the provided online link. The contract remains active and is set to be archived on September 20, 2025.

Department Of Veterans AffairsIL, USA$3.2M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0033

Awarded Jul 22, 2025

Awarded1

6505--Tamsulosin Capsules - Exelan Pharmaceuticals

The Department of Veterans Affairs (VA) National Acquisition Center plans to issue a Request for Proposal (RFP) for an unrestricted procurement of Tamsulosin Hydrochloride (HCL) Capsules, intended for use across VA facilities, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing a continuous supply of the specified medication, with an initial period of one year plus four optional one-year extensions. The procurement emphasizes strict labeling requirements, including a unique National Drug Code (NDC) assigned to the contractor’s label, which must be the sole label on the product, and specific packaging specifications for safety caps and bottle dimensions to ensure safety and compatibility with existing pharmacy systems. The solicitation is expected to be released electronically around January 7, 2025, with a deadline for responses set for January 21, 2025, and will be available exclusively through SAM.gov, with no paper copies provided. The estimated annual demand for Tamsulosin HCL capsules is approximately 1.4 million bottles of 90 capsules each, with additional requirements for larger bottle sizes (500 or 1000 capsules), reflecting significant procurement volume. The NAICS code associated with this procurement is 325412, indicating pharmaceutical manufacturing. Interested vendors are encouraged to monitor SAM.gov for updates and amendments, and all submissions must be made electronically. The primary point of contact is Contract Specialist Andrew Cazares, who can be reached via email or phone for inquiries. This procurement aims to ensure an uninterrupted supply of this medication to support veteran and federal healthcare operations.

Department Of Veterans AffairsIL, USA$88.2M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0011

Awarded Jul 8, 2025

Awarded1

6505--Loperamide Capsules - GSMS

This contract involves the procurement of Loperamide Hydrochloride (HCL) 2mg capsules for the Department of Veterans Affairs, with a solicitation posted under number 36E79725R0025. The award will be made in the aggregate for specific line items, requiring offerors to submit pricing for a base year plus four additional one-year options, with prices to be listed to two decimal places and inclusive of a 0.5% Cost Recovery Fee. The contract emphasizes the importance of providing a unique 11-digit NDC number for each drug offered, whether from a manufacturer or distributor, to ensure proper identification. The solicitation is open until April 23, 2025, at 7:30 PM CT, and the contract is administered from the VA’s National Acquisition Center in Hines, Illinois. The process incorporates standard FAR clauses, including FAR 52.212-1 and FAR 52.212-4, with additional terms specified in attachments. The contract aims to establish a reliable supply of the specified pharmaceutical product, with detailed instructions for submission, pricing, and compliance outlined for potential offerors.

Department Of Veterans AffairsIL, USA$7.8M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0025

Awarded Jul 7, 2025

Awarded1

6505--Bupropion Tablets

The Department of Veterans Affairs, through the National Acquisition Center, has issued an award notice for the procurement of Bupropion Tablets under solicitation number 36E79724R0029. The contract, identified as award number 36E79725D0010, was granted to The Harvard Drug Group, L.L.C. on December 31, 2024. The total value of the award is 2,936,792.25 dollars. This procurement falls under NAICS code 325412 and is managed by the office located in Hines, Illinois. Andrew J. Cazares serves as the Contract Specialist for this action.

Department Of Veterans AffairsIL, USA$2.9M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79724R0029

Awarded Dec 31, 2024